American Stock Exchange to Trade Options on Five Securities
18 10월 2005 - 5:09AM
PR Newswire (US)
NEW YORK, Oct. 17 /PRNewswire/ -- The American Stock Exchange(R)
(Amex(R)) will launch trading in options on Tuesday, October 18,
2005 on the following Nasdaq Stock Market and New York Stock
Exchange listed stocks of: * Cypress Bioscience, Inc. (Option
Symbol: QGY/Stock Symbol: CYPB) * Holly Corporation (Symbol: HOC) *
Panacos Pharmaceuticals Inc. (Option Symbol: PBQ/Stock Symbol:
PANC) * StemCells, Inc. (Option Symbol: QTB/Stock Symbol: STEM) *
Titanium Metals Corporation (Symbol: TIE) Cypress Bioscience, Inc.
options will open with position limits of 7,500,000 shares. The
options will trade on the March expiration cycle. The Specialist
will be Kellogg Capital Group, LLC. Cypress Bioscience, Inc.
provides products that improve the diagnosis and treatment of
Functional Somatic Syndromes and other related pain and central
nervous system conditions. Holly Corporation options will open with
position limits of 5,000,000 shares. The options will trade on the
March expiration cycle. The Specialist will be Susquehanna
Investment Group. Holly Corporation, through its affiliates,
refines, transports, stores and markets petroleum products. The
Company's refineries produce light products such as gasoline,
diesel fuel and jet fuel, which are marketed in the southwestern
United States, northern Mexico and Montana. Panacos Pharmaceuticals
Inc. options will open with position limits of 25,000,000 shares.
The options will trade on the January expiration cycle. The
Specialist will be Jane Street Specialists, LLC. Panacos
Pharmaceuticals Inc. discovers, develops and commercializes small
molecule drugs to treat or prevent serious infectious disease. The
Company is currently focused on a new class of drugs to treat HIV
infection. StemCells, Inc. options will open with position limits
of 25,000, 000 shares. The options will trade on the March
expiration cycle. The Specialist will be Jane Street Specialists,
LLC. StemCells, Inc. is a biotechnology company. The Company
discovers, develops and commercializes stem cell-based therapies to
treat diseases of the central nervous system, liver and the
pancreas. StemCells seeks to repair or repopulate neural or other
tissue that has been damaged or lost as a result of disease or
injury. Titanium Metals Corporation options will open with position
limits of 7,500,000 shares. The options will trade on the March
expiration cycle. The Specialist will be Group One Trading, LP.
Titanium Metals Corporation supplies titanium metal products. The
titanium products are used in aerospace, industrial and emerging
applications. The Company converts rutile ore into sponge, melts
and refines ingot and slab, and manufactures mill products and
castings. For more information on any Amex-listed company, please
visit http://www.amex.com/. The American Stock Exchange(R)
(Amex(R)) is the only primary exchange that offers trading across a
full range of equities, options and exchange traded funds (ETFs),
including structured products and HOLDRS(SM). In addition to its
role as a national equities market, the Amex is the pioneer of the
ETF, responsible for bringing the first domestic product to market
in 1993. Leading the industry in ETF listings, the Amex lists 169
ETFs. The Amex is also one of the largest options exchanges in the
U.S., trading options on broad-based and sector indexes as well as
domestic and foreign stocks. For more information, please visit
http://www.amex.com/. DATASOURCE: The American Stock Exchange
CONTACT: Mary Chung of American Stock Exchange, +1-212-306-1641,
Web site: http://www.amex.com/
Copyright